Revised SPC: Pelgraz (pegfilgrastim) 6 mg solution for injection in pre-filled syringe

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
05 December 2019

Abstract

SPC updated to include Stevens-Johnson syndrome, as a rare (=1/10,000 to <1/1,000) adverse effect of pegfilgrastim treatment. If the patient has developed SJS, SPC advises treatment with pegfilgrastim must not be restarted for that patient at any time.